Akums Drugs and Pharmaceutical Capital Reinvestment Ratio
Akums Drugs and Pharmaceutical capital reinvestment ratio. Akums Drugs and Pharmaceutical (AKUMS) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs11.52 Billion) in capital expenditures (Rs1.12 Billion). Check Akums Drugs and Pharmaceutical (AKUMS) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Akums Drugs and Pharmaceutical (2022–2026)
Capital reinvestment ratio of Akums Drugs and Pharmaceutical from 2022 to 2026. This chart tracks Akums Drugs and Pharmaceutical's Capital Reinvestment Ratio across 5 annual periods. Also explore net asset momentum of Akums Drugs and Pharmaceutical to track the company's year-over-year net asset growth rate.
Akums Drugs and Pharmaceutical Capital Reinvestment Ratio by Year (2022–2026)
Akums Drugs and Pharmaceutical capital reinvestment ratio by year from 2022 to 2026. For the full cash flow conversion analysis, see cash flow conversion of Akums Drugs and Pharmaceutical.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.19x | Rs12.11 Billion | Rs2.31 Billion | ▼ -67.5% |
| 2025 | 0.59x | Rs4.65 Billion | Rs2.72 Billion | ▼ -6.3% |
| 2024 | 0.62x | Rs4.98 Billion | Rs3.11 Billion | ▼ -66.4% |
| 2023 | 1.86x | Rs1.77 Billion | Rs3.29 Billion | ▼ -77.0% |
| 2022 | 8.09x | Rs318.54 Million | Rs2.58 Billion | — |